ORIC PHARMACEUTICALS, INC. (ORIC) Operating cash flow 2018–2025
ORIC PHARMACEUTICALS, INC. (ORIC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$111.0MFY2025 · since FY2018: -$20.7M → -$111.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.0M | +1.5% |
| FY2024 | -$112.7M | -31.5% |
| FY2023 | -$85.7M | -14.0% |
| FY2022 | -$75.1M | -26.2% |
| FY2021 | -$59.5M | -31.5% |
| FY2020 | -$45.3M | -92.4% |
| FY2019 | -$23.5M | -13.8% |
| FY2018 | -$20.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORIC financial trends
ORIC RevenueORIC Net incomeORIC Net marginORIC Gross profitORIC Gross marginORIC Operating incomeORIC Operating marginORIC Free cash flowORIC Capital expendituresORIC Return on equityORIC Stock buybacksORIC Dividends paidORIC Total assetsORIC Total liabilitiesORIC Shareholders’ equityORIC overview →